March 18, 2025 (press release) –
In response to recent news of the cancellation of funding for the National Diabetes Prevention Program, the American Diabetes Association® (ADA) issued the following statement:
“The American Diabetes Association® (ADA) is extremely concerned about the impact of canceled National Institutes of Health funding on the success of the National Diabetes Prevention Program (National DPP), which was established to support people at risk of type 2 diabetes. The evidence-based lifestyle change program has been proven effective in reducing the risk of developing diabetes.
Eliminating funding for the National DPP’s 30-year nationwide study of program participants means the loss of a decade’s worth of important findings and progress toward diabetes prevention. The ADA is engaging with congressional leaders on diabetes and the Trump administration to express our concerns, especially as this funding decision seems to be at odds with the Department of Health and Human Services’ commitment to combatting chronic disease in the United States.”
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure —and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.